NCT03466502

Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics

Efficacy of Prophylactic Oral Vancomycin in Preventing Recurrent Clostridium Difficile Infection in Hospitalized Patients Requiring Antibiotics

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 104 (actual)
• Sponsor: University of Nevada, Reno · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will assess the efficacy of oral vancomycin prophylaxis in preventing recurrent Clostridium difficile infection in hospitalized patients requiring oral or intravenous antibiotics for a suspected or confirmed bacterial infection.

Detailed description

This study will assess the efficacy of oral vancomycin prophylaxis in preventing recurrent Clostridium difficile infection in hospitalized patients requiring oral or intravenous antibiotics for a suspected or confirmed bacterial infection.

Conditions

• Clostridium Difficile Infection

Interventions

Type	Name	Description
DRUG	Oral Vancomycin	Oral vancomycin will be given concurrently with antibiotics to hospitalized patients with a history of Clostridium difficile infection to prevent recurrence

Timeline

• Start date: 2018-03-08
• Primary completion: 2022-02-17
• Completion: 2022-02-17
• First posted: 2018-03-15
• Last updated: 2023-11-28

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study